Sbir phase i: platform for rapid assessment of hydrolytic enzyme activity to optimize their design and use

Ended Project Grant Awarded Last action

Award ID
2126748
Recipient
Awarding agency
Obligated
$256,000

Award facts

Assistance listing
47.041 Engineering
Completion date
Place of performance
Ames, IA 50010, USA

Award details come from USAspending.gov.

About this award

Zymosense Inc. received a $256,000 Project Grant award from the National Science Foundation Division of Industrial Innovation on December 1, 2021 to develop a platform for rapid assessment of hydrolytic enzyme activity to optimize their design and use. The award is being carried out under the Engineering program (CFDA 47.041) of the NSF Directorate for Engineering, which seeks to improve quality of life and economic strength through engineering research and innovation. Under this one-year project concluding on November 30, 2022, Zymosense is delivering a platform that will assess hydrolytic enzymes to enable optimization of their design and applications in a more rapid and efficient manner. The platform and results of this research have the potential to advance engineering capabilities in related fields.

Quick answers

Who received award 2126748?

2126748 was awarded to Zymosense Inc. by Division of Industrial Innovation (National Science Foundation) on December 1, 2021.

How much is award 2126748 worth?

$256,000 has been obligated on 2126748.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award